Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis
Abstract Background Statins, metformin, and aspirin have been reported to reduce the incidence of hepatocellular carcinoma (HCC). However, the effect of their perioperative use on survival outcomes of HCC patients following curative liver resection still remains unclear. Method Three hundred and fif...
Main Authors: | Elias Khajeh, Ehsan Aminizadeh, Arash Dooghaie Moghadam, Ali Ramouz, Rosa Klotz, Mohammad Golriz, Uta Merle, Christoph Springfeld, De‐Hua Chang, Thomas Longerich, Markus W. Büchler, Arianeb Mehrabi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6569 |
Similar Items
-
Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population‐based cohort study in Korea with systematic review and meta‐analysis
by: Seung In Seo, et al.
Published: (2022-02-01) -
Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention
by: Mark A Moyad, et al.
Published: (2015-01-01) -
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
by: L. Lukas Löfling, et al.
Published: (2023-08-01) -
Analysis of the Dilemma Involving Statins and Aspirin as Primary Prevention Alternatives in Cardiovascular Disease
by: Henry Sutanto
Published: (2017-10-01) -
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
by: Myung Ji Goh, et al.
Published: (2022-07-01)